Clinical Decision Support Systems Market worth 1,752.0 Million USD by 2023 | Cerner Corporation, McKesson Corporation, Epic Systems Corporation Inc., Medical Information Technology, Inc., Philips Healthcare, Allscripts Healthcare Solutions, Inc., Wolters

The report "Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), Patient Care Setting - Global Forecasts to 2023", The clinical decision support systems (CDSS) market is expected to reach USD 1,752.0 Million by 2023 from USD 1,001.9 Million in 2018, at a CAGR of 11.8%. The key factors driving the growth of this market include the government support & initiatives, growing incidence of medication errors, rising prominence & usage of big data and m-health tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare.

Browse 114 market data Tables and 36 Figures spread through 199 Pages and in-depth TOC on "Clinical Decision Support Systems Market"
https://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html?utm_source=OpenPR_19_Dec_2018&utm_medium=Paid-PR
Early buyers will receive 10% customization on reports.

Services segment to dominate the CDSS market, by component in 2017

By component, CDSS market is segmented into services, software, and hardware. The services segment accounted for the largest share of the global CDSS market, by component, in 2017. The largest share of this segment can be attributed to the recurring nature of services such as training and development, installation, software upgrades, consulting, and maintenance. However, due to the need for periodic software upgradation, the software segment is expected to witness the highest growth during the forecast period.

By delivery mode, cloud-based systems to register the highest CAGR during the forecast period

On the basis of delivery mode, the CDSS market is segmented into on-premise and cloud-based systems. Cloud-based CDSS segment is expected to register the highest CAGR of the global CDSS market during the forecast period. The high growth of the segment can be attributed to the comparatively lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability.

Make an Inquiry:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=18085342&utm_source=OpenPR_19_Dec_2018&utm_medium=Paid-PR

By product, integrated CDSS to dominate the market in 2017

On the basis of delivery mode, the CDSS market is segmented into integrated and standalone systems. Integrated CDSS segment accounted for the largest share of the CDSS market, by product, in 2017 and also witness the highest growth during the forecast period. The large share and high growth of the segment can be attributed to the growing deployments of integrated CDSS.

North America to dominate the market in 2017

Geographically, the global CDSS market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share in 2017 owing to factors such as regulatory mandates, the prevalence of chronic diseases, rising incidence of medication errors, and increasing HCIT expenditure. North America is followed by Europe and Asia Pacific. The Asia Pacific market is relatively nascent; however, it is projected to be the fastest growing market during the forecast period.

Request Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=18085342&utm_source=OpenPR_19_Dec_2018&utm_medium=Paid-PR

Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation Inc. (US), Medical Information Technology, Inc. (US), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (US), Wolters Kluwer Health (US), Hearst Health (US), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (US) are the key players in the global CDSS market.

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deep

MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441

UK : +44-800-368-9399
sales@marketsandmarkets.com

This release was published on openPR.